AUTL
Autolus Therapeutics
AUTL
AUTL
46 hedge funds and large institutions have $344M invested in Autolus Therapeutics in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
40% less capital invested
Capital invested by funds: $569M → $344M (-$225M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
46
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$17.1M | |
| 2 | +$10.4M | |
| 3 | +$6.02M | |
| 4 |
Millennium Management
New York
|
+$5.11M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$4.55M |
Top Sellers
| 1 | -$7.2M | |
| 2 | -$2.42M | |
| 3 | -$378K | |
| 4 |
Goldman Sachs
New York
|
-$274K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$249K |